PTN
Price
$0.77
Change
-$0.00 (-0.00%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
20.09M
70 days until earnings call
VTGN
Price
$2.73
Change
+$0.08 (+3.02%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
77.06M
Ad is loading...

PTN vs VTGN

Header iconPTN vs VTGN Comparison
Open Charts PTN vs VTGNBanner chart's image
Palatin Technologies
Price$0.77
Change-$0.00 (-0.00%)
Volume$9.39K
Capitalization20.09M
VistaGen Therapeutics
Price$2.73
Change+$0.08 (+3.02%)
Volume$810
Capitalization77.06M
PTN vs VTGN Comparison Chart
Loading...
PTN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PTN vs. VTGN commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTN is a Hold and VTGN is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (PTN: $0.77 vs. VTGN: $2.65)
Brand notoriety: PTN and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PTN: 34% vs. VTGN: 65%
Market capitalization -- PTN: $20.09M vs. VTGN: $77.06M
PTN [@Biotechnology] is valued at $20.09M. VTGN’s [@Biotechnology] market capitalization is $77.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTN’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • PTN’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, VTGN is a better buy in the long-term than PTN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTN’s TA Score shows that 4 TA indicator(s) are bullish while VTGN’s TA Score has 3 bullish TA indicator(s).

  • PTN’s TA Score: 4 bullish, 6 bearish.
  • VTGN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, PTN is a better buy in the short-term than VTGN.

Price Growth

PTN (@Biotechnology) experienced а -9.11% price change this week, while VTGN (@Biotechnology) price change was +6.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.61%. For the same industry, the average monthly price growth was -8.15%, and the average quarterly price growth was -7.40%.

Reported Earning Dates

PTN is expected to report earnings on May 20, 2025.

VTGN is expected to report earnings on Aug 10, 2023.

Industries' Descriptions

@Biotechnology (+0.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTGN($77.1M) has a higher market cap than PTN($20.1M). VTGN YTD gains are higher at: -10.000 vs. PTN (-30.405). PTN has higher annual earnings (EBITDA): -26.62M vs. VTGN (-52.22M). VTGN has more cash in the bank: 88.6M vs. PTN (3.42M). PTN has less debt than VTGN: PTN (358K) vs VTGN (1.71M). VTGN has higher revenues than PTN: VTGN (698K) vs PTN (350K).
PTNVTGNPTN / VTGN
Capitalization20.1M77.1M26%
EBITDA-26.62M-52.22M51%
Gain YTD-30.405-10.000304%
P/E RatioN/AN/A-
Revenue350K698K50%
Total Cash3.42M88.6M4%
Total Debt358K1.71M21%
FUNDAMENTALS RATINGS
PTN vs VTGN: Fundamental Ratings
PTN
VTGN
OUTLOOK RATING
1..100
8872
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
48
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9583
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (48) in the Biotechnology industry is in the same range as PTN (73). This means that VTGN’s stock grew similarly to PTN’s over the last 12 months.

VTGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PTN (100). This means that VTGN’s stock grew similarly to PTN’s over the last 12 months.

VTGN's SMR Rating (100) in the Biotechnology industry is in the same range as PTN (100). This means that VTGN’s stock grew similarly to PTN’s over the last 12 months.

VTGN's Price Growth Rating (83) in the Biotechnology industry is in the same range as PTN (95). This means that VTGN’s stock grew similarly to PTN’s over the last 12 months.

PTN's P/E Growth Rating (95) in the Biotechnology industry is in the same range as VTGN (100). This means that PTN’s stock grew similarly to VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PTNVTGN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 8 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 8 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 8 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 8 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 8 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 19 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 8 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 8 days ago
87%
View a ticker or compare two or three
Ad is loading...
PTN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X78532.000000-2069.039000
-2.57%
Bitcoin cryptocurrency
SPY560.58-15.34
-2.66%
SPDR® S&P 500® ETF Trust
AAPL227.48-11.59
-4.85%
Apple
GME22.42-1.58
-6.58%
GameStop Corp
TSLA222.15-40.52
-15.43%
Tesla

PTN and

Correlation & Price change

A.I.dvisor tells us that PTN and KRYS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTN and KRYS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTN
1D Price
Change %
PTN100%
-1.59%
KRYS - PTN
32%
Poorly correlated
+2.12%
RYTM - PTN
32%
Poorly correlated
-4.39%
VTGN - PTN
31%
Poorly correlated
-3.80%
AVIR - PTN
30%
Poorly correlated
-2.34%
DNLI - PTN
28%
Poorly correlated
-10.43%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with ABOS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-3.80%
ABOS - VTGN
43%
Loosely correlated
-4.00%
KYMR - VTGN
38%
Loosely correlated
+0.40%
SRRK - VTGN
38%
Loosely correlated
-2.36%
ATAI - VTGN
37%
Loosely correlated
-6.62%
ALEC - VTGN
37%
Loosely correlated
-3.47%
More